| abstract |
The present invention relates to the ability of anti-FcγR antibodies and aggregated or cross-linked IgG to suppress fibrocytes differentiation. Methods and compositions for suppressing fibrocyte differentiation using these antibodies are provided. These methods are useful in a variety of applications including treatment and prevention of conditions resulting from fibrosis in the kidney, liver, lung, heart, eye, uterus, tumors, and wounds. |